HRS-4508 and Anti-tumor Therapy for Solid Tumor

This clinical trial is exploring a new treatment option for people with solid tumors, which are abnormal masses of tissue that can occur in various organs. The study aims to determine how effective and safe a combination of different anti-cancer therapies, including a new drug called HRS-4508, is for these patients. This research is crucial because finding a more effective treatment could significantly improve outcomes for individuals with these types of cancers, which are often challenging to treat with existing options. Participants in the study will receive HRS-4508 along with other cancer treatments, and their response to the treatment will be closely monitored. Researchers will measure how well the tumors respond using specific criteria and will also keep track of any side effects experienced. By understanding the best dosage and potential adverse reactions, the study aims to establish a safe and effective treatment regimen. The study also examines how the body absorbs, distributes, and processes HRS-4508 and other drugs used in the combination, providing comprehensive data on their behavior within the body.